Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Alzheimer’s disease

A TREM2 antibody energizes microglia

Loss-of-function variants of TREM2 increase risk for Alzheimer’s disease. A new study presents a therapeutic candidate — ATV:TREM2, a TREM2-activating antibody engineered with a transferrin receptor binding site to facilitate blood-to-brain transport. Treatment of a mouse model of Alzheimer’s disease with ATV:TREM2 improved energy metabolism and microglial function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: An engineered AVT:TREM2 antibody for blood-to-brain transport and targeted activation of microglia.

References

  1. Guerreiro, R. et al. N. Engl. J. Med. 368, 117–127 (2013).

    Article  CAS  PubMed  Google Scholar 

  2. Jonsson, T. et al. N. Engl. J. Med. 368, 107–116 (2013).

    Article  CAS  PubMed  Google Scholar 

  3. Ulland, T. K. et al. Cell 170, 649–663.e13 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ulland, T. K. & Colonna, M. Nat. Rev. Neurol. 14, 667–675 (2018).

    Article  CAS  PubMed  Google Scholar 

  5. Wang, S. et al. J. Exp. Med. 217, e20200785 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Schlepckow, K. et al. EMBO Mol. Med. 12, e11227 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Van Lengerich, B. et al. Nat. Neurosci. https://doi.org/10.1038/s41593-022-01240-0 (2023).

    Article  PubMed  Google Scholar 

  8. Friden, P. M. et al. Proc. Natl Acad. Sci. USA 88, 4771–4775 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kariolis, M. S. et al. Sci. Transl. Med. 12, eaay1359 (2020).

    Article  CAS  PubMed  Google Scholar 

  10. Keren-Shaul, H. et al. Cell 169, 1276–1290.e17 (2017).

    Article  CAS  PubMed  Google Scholar 

  11. Andreone, B. J. et al. Nat. Neurosci. 23, 927–938 (2020).

    Article  CAS  PubMed  Google Scholar 

  12. Zhao, P. et al. Sci. Transl. Med. 14, eabq0095 (2022).

    Article  CAS  PubMed  Google Scholar 

  13. Shin, J. W. et al. Cell Rep. Methods 2, 100338 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhao, N. et al. J. Exp. Med. 219, e20212479 (2022).

    Article  CAS  PubMed  Google Scholar 

  15. Parhizkar, S. et al. Nat. Neurosci. 22, 191–204 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jain, N., Lewis, C. A., Ulrich, J. D. & Holtzman, D. M. J. Exp. Med. 220, e20220654 (2023).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

N.Z. is supported by NIH/NIA grant R01AG066395.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Na Zhao or Guojun Bu.

Ethics declarations

Competing interests

G.B. is an employee of SciNeuro Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, N., Bu, G. A TREM2 antibody energizes microglia. Nat Neurosci 26, 366–368 (2023). https://doi.org/10.1038/s41593-023-01265-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41593-023-01265-z

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research